CAI news

Latest 1 stories · newest Nov 4, 2026

CAI

Caris Life Sciences Q3 2026 revenue up 27% to $275.4 million

Caris Life Sciences reported a 27% revenue increase to $275.4 million for Q3 2026, surpassing prior-year performance in molecular profiling services and raising full-year revenue guidance to a range of $1.04 to $1.05 billion.

Earnings|Guidance Nov 4, 2026 sentiment +0.80 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CAI feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CAI/newsSTART FREE